Evidence map›Paper›PMID 30061786›Full record

ArticleActa informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH2018

Management and Invasive Cardiological Review by Comparison of Percutaneous Coronary Intervention in Left Anterior Descending Artery with Drug Eluting and Bare Metal Stents.

Majla Cibo, Lejla Brigic, Sanela Tukulija, Nihad Kukavica, Amer Iglica, Merita Tiric-Campara

Abstract read
In one paragraph

Article in Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Majla CiboClinic for Heart Disease, Blood Vessels Diseases and Rheumatism; Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Lejla BrigicClinic for Heart Disease, Blood Vessels Diseases and Rheumatism; Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Sanela TukulijaInstitute for Public Health; Federation of Bosnia and Herzegovina; Sarajevo, Bosnia and Herzegovina.
Nihad KukavicaClinic for Heart Disease, Blood Vessels Diseases and Rheumatism; Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Amer IglicaClinic for Heart Disease, Blood Vessels Diseases and Rheumatism; Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Merita Tiric-CamparaClinic for Neurology; University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina.
Clinical Center University of Sarajevo · BAPublic Health Institute of the Republic of Srpska · BAUniversity of Sarajevo · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe dominant global public health challenge are non-communicable diseases. According to World Health Organization (WHO) data. The fifth leading causes of death in FB&H are diseases of the heart and coronary arteries: stroke, acute myocardial infarction, cardiac arrest, cardiomyopathy and essential hypertension. The prevention of these diseases has great importance in improving health in B&H.

objectiveThe aim of this study is in estimation of one-year survival and left heart systolic function after the treatment. After the data collection and evidence of their statistical value, the results of the research point to the profile of patients with a LAD disease in one-vessel coronary artery disease that should be subjected to PCI DES LAD and PCI BMS LAD, respectively, or creating guidelines for a better and more effective LAD treatment. MATERIAL AND

methodsThe study was performed as retrospective/ prospective, clinically controlled for a period of three years. In this study was included 60 patients, which was followed in 12 months period. With the PCI BMS method was treated 63.3% and 36.7% of subjects were treated with the PCI DES in LAD.

conclusionThe number of complications in patients with one-vessel LAD coronary heart disease, treated with PCI DES and PCI BMS was statistically significant. One possible complication (4 patients) is due to the spread of the disease to other blood vessels. Due to possible complications in the treated or LAD with repeated stenosis, the complication in terms of restenosis of the previously placed stent in 75% are with BM stents justifying the use of drug eluting stent, while the progression of disease in patients (2 patients) indicates the need for detection and prevention of risk factors.

Indexed as

acute coronary syndromebare metal stentdrug eluting stentleft anterior descending artery

Identifiers

PMID30061786
PMCPMC6029904
OpenAlexW2805533798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.